Predictive factors for survival in patients with oligohydramnios secondary to antenatal kidney disease.
Antenatal counseling
CAKUT
Oligohydramnios
Posterior urethral valves
Prognostic factors
Renal dysplasia
Survival
Journal
Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
09
05
2022
accepted:
24
10
2022
revised:
24
10
2022
medline:
4
5
2023
pubmed:
22
11
2022
entrez:
21
11
2022
Statut:
ppublish
Résumé
Renal oligohydramnios (ROH) is caused by bilateral congenital abnormalities, either of renal parenchymal or obstructive origin. ROH is a poor prognostic factor of neonatal survival; lung hypoplasia is reported to be the main cause of mortality. We aimed to describe the fetal morbidity and pre- and postnatal mortality in case of ROH due to renal congenital pathologies and to find predictive risk factors for morbidity and mortality. All data were collected in Trousseau Hospital in the obstetric, neonatology, and pediatric nephrology units, from 2008 to 2020. We included 66 fetuses with renal parenchymal pathologies posterior urethral valves (PUV) (N = 25), bilateral kidney agenesis (N = 10), hypodysplasia (N = 16), and polycystic kidney disease (N = 10) causing oligohydramnios identified on antenatal ultrasound. Total pre- and postnatal mortality was 76% (50/66). Mortality, excepting termination of pregnancy (TOP), was 65%. The presence of pneumomediastinum and pneumothorax was not different in survivors and non-survivors. Fetuses with kidneys having features of hypodysplasia on ultrasound at T2 and those with oligohydramnios before 32 weeks GA had a higher risk of death. There was a significant difference in plasma creatinine of the surviving patients compared to the deceased patients, from day 3 onwards (183 µmol/L [88; 255] vs. 295 µmol/L [247; 326]; p = 0.038). The main differences between survivors and non-survivors among patients with "renal oligohydramnios" were oligohydramnios detection before 32 weeks GA, dysplasia detection on the second trimester ultrasound, and increase of serum creatinine from day 3 onwards. A higher resolution version of the Graphical abstract is available as Supplementary information.
Sections du résumé
BACKGROUND
Renal oligohydramnios (ROH) is caused by bilateral congenital abnormalities, either of renal parenchymal or obstructive origin. ROH is a poor prognostic factor of neonatal survival; lung hypoplasia is reported to be the main cause of mortality. We aimed to describe the fetal morbidity and pre- and postnatal mortality in case of ROH due to renal congenital pathologies and to find predictive risk factors for morbidity and mortality.
METHODS
All data were collected in Trousseau Hospital in the obstetric, neonatology, and pediatric nephrology units, from 2008 to 2020.
RESULTS
We included 66 fetuses with renal parenchymal pathologies posterior urethral valves (PUV) (N = 25), bilateral kidney agenesis (N = 10), hypodysplasia (N = 16), and polycystic kidney disease (N = 10) causing oligohydramnios identified on antenatal ultrasound. Total pre- and postnatal mortality was 76% (50/66). Mortality, excepting termination of pregnancy (TOP), was 65%. The presence of pneumomediastinum and pneumothorax was not different in survivors and non-survivors. Fetuses with kidneys having features of hypodysplasia on ultrasound at T2 and those with oligohydramnios before 32 weeks GA had a higher risk of death. There was a significant difference in plasma creatinine of the surviving patients compared to the deceased patients, from day 3 onwards (183 µmol/L [88; 255] vs. 295 µmol/L [247; 326]; p = 0.038).
CONCLUSIONS
The main differences between survivors and non-survivors among patients with "renal oligohydramnios" were oligohydramnios detection before 32 weeks GA, dysplasia detection on the second trimester ultrasound, and increase of serum creatinine from day 3 onwards. A higher resolution version of the Graphical abstract is available as Supplementary information.
Identifiants
pubmed: 36409365
doi: 10.1007/s00467-022-05800-1
pii: 10.1007/s00467-022-05800-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1783-1792Informations de copyright
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
Références
Dolk H, Loane M, Garne E (2010) The prevalence of congenital anomalies in Europe. In: Posada de la Paz M, Groft SC (eds) Rare diseases epidemiology, vol 686. Springer Netherlands, Dordrecht, pp 349–364
doi: 10.1007/978-90-481-9485-8_20
Gimpel C, Avni FE, Bergmann C, Cetiner M, Habbig S, Haffner D, König J, Konrad M, Liebau MC, Pape L, Rellensmann G, Titieni A, von Kaisenberg C, Weber S, Winyard PJD, Schaefer F (2018) Perinatal diagnosis, management, and follow-up of cystic renal diseases: a clinical practice recommendation with systematic literature reviews. JAMA Pediatr 172:74–86
Couture A, Baud C, Saguintaah M, Veyrac C (2009) Hypoplasie et agénésie pulmonaire: génétique et environement. Les malformations congénitale. Editions Sauramps medical, Paris
Brace RA (1997) Physiology of amniotic fluid volume regulation. Clin Obstet Gynecol 40:280–289
doi: 10.1097/00003081-199706000-00005
pubmed: 9199840
Tomotaki S, Toyoshima K, Shimokaze T, Shibasaki J, Nagafuchi H (2017) Association between cord blood cystatin C levels and early mortality of neonates with congenital abnormalities of the kidney and urinary tract: a single-center, retrospective cohort study. Pediatr Nephrol 32:2089–2095
doi: 10.1007/s00467-017-3733-1
pubmed: 28681080
Herbst KW, Tomlinson P, Lockwood G, Mosha MH, Wang Z, D’Alessandri-Silva C (2019) Survival and kidney outcomes of children with an early diagnosis of posterior urethral valves. Clin J Am Soc Nephrol 14:1572–1580
doi: 10.2215/CJN.04350419
pubmed: 31582461
pmcid: 6832049
Shuster S, Keunen J, Shannon P, Watkins N, Chong K, Chitayat D (2019) Prenatal detection of isolated bilateral hyperechogenic kidneys: etiologies and outcomes. Prenat Diagn 39:693–700
doi: 10.1002/pd.5418
pubmed: 30650191
Morris RK, Quinlan-Jones E, Kilby MD, Khan KS (2007) Systematic review of accuracy of fetal urine analysis to predict poor postnatal renal function in cases of congenital urinary tract obstruction. Prenat Diagn 27:900–911
doi: 10.1002/pd.1810
pubmed: 17610312
Mehler K, Gottschalk I, Burgmaier K, Volland R, Büscher AK, Feldkötter M, Keller T, Weber LT, Kribs A, Habbig S (2018) Prenatal parental decision-making and postnatal outcome in renal oligohydramnios. Pediatr Nephrol 33:651–659
doi: 10.1007/s00467-017-3812-3
pubmed: 29075889
Grijseels EW, van-Hornstra PT, Govaerts LC, Cohen-Overbeek TE, de Krijger RR, Smit BJ, Cransberg K (2011) Outcome of pregnancies complicated by oligohydramnios or anhydramnios of renal origin. Prenat Diagn 31(1039):1045
Spiro JE, Konrad M, Rieger-Fackeldey E, Masjosthusmann K, Amler S, Klockenbusch W, Schmitz R (2015) Renal oligo- and anhydramnios: cause, course and outcome—a single-center study. Arch Gynecol Obstet 292:327–336
doi: 10.1007/s00404-015-3648-7
pubmed: 25676656
Loos S, Kemper MJ (2018) Causes of renal oligohydramnios: impact on prenatal counseling and postnatal outcome. Pediatr Nephrol 33:541–545
doi: 10.1007/s00467-017-3833-y
pubmed: 29128922
Oliveira EA, Diniz JS, Cabral AC, Leite HV, Colosimo EA, Oliveira RB, Vilasboas AS (1999) Prognostic factors in fetal hydronephrosis: a multivariate analysis. Pediatr Nephrol 13:859–864
doi: 10.1007/s004670050716
pubmed: 10603137
Sarhan OM (2017) Posterior urethral valves: impact of low birth weight and preterm delivery on the final renal outcome. Arab J Urol 15:159–165
doi: 10.1016/j.aju.2017.01.005
pubmed: 29071146
pmcid: 5653607
Sarhan OM, El-Ghoneimi AA, Helmy TE, Dawaba MS, Ghali AM, Ibrahiem E-HI (2011) Posterior urethral valves: multivariate analysis of factors affecting the final renal outcome. J Urol 185:2491–2496
doi: 10.1016/j.juro.2011.01.023
pubmed: 21555022
Morris R, Malin G, Khan K, Kilby M (2009) Antenatal ultrasound to predict postnatal renal function in congenital lower urinary tract obstruction: systematic review of test accuracy: antenatal ultrasound to predict postnatal renal function in LUTO. BJOG 116:1290–1299
doi: 10.1111/j.1471-0528.2009.02194.x
pubmed: 19438489
Kumar M, Thakur S, Puri A, Shukla S, Sharma S, Perumal V, Chawla R, Gupta U (2014) Fetal renal anomaly: factors that predict survival. J Pediatr Urol 10:1001–1007
doi: 10.1016/j.jpurol.2014.11.007
pubmed: 25486943
Carmody JB, Charlton JR (2013) Short-term gestation, long-term risk: prematurity and chronic kidney disease. Pediatrics 131:1168–1179
doi: 10.1542/peds.2013-0009
pubmed: 23669525
Melo BF, Aguiar MB, Bouzada MC, Aguiar RL, Pereira AK, Paixão GM, Linhares MC, Valerio FC, Simões e Silva AC, Oliveira EA (2012) Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns. Pediatr Nephrol 27:965–972
doi: 10.1007/s00467-012-2107-y
pubmed: 22402647
Coquillette M, Lee RS, Pagni SE, Cataltepe S, Stein DR (2020) Renal outcomes of neonates with early presentation of posterior urethral valves: a 10-year single center experience. J Perinatol 40:112–117
doi: 10.1038/s41372-019-0489-4
pubmed: 31471579
Klaassen I, Neuhaus TJ, Mueller-Wiefel DE, Kemper MJ (2006) Antenatal oligohydramnios of renal origin: long-term outcome. Nephrol Dial Transplant 22:432–439
doi: 10.1093/ndt/gfl591
pubmed: 17065192